Ning Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ning Dai has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Fei Ji
Department of Molecular Biology, Massachusetts General Hospital, Boston, MA
2 shared publicationsJoseph Avruch
Department of Molecular Biology, Massachusetts General Hospital, Boston, MA
2 shared publicationsLaura Regué
Department of Molecular Biology, Massachusetts General Hospital, Boston, MA
2 shared publicationsHua Wang
The Lundquist Institute, Harbor-UCLA, Torrance, CA, 90502, USA
1 shared publication- Hua Wang
The Lundquist Institute, Torrance, CA
1 shared publication Liping Zhao
Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA
1 shared publication
Latest Publications
- Open Access
- 11 October 2022
- Published by American Diabetes Association in Diabetes
- Vol. 72 (1) , 33-44
Human T2D-Associated Gene IMP2/IGF2BP2 Promotes the Commitment of Mesenchymal Stem Cells Into Adipogenic Lineage
Excessive adiposity is the main cause of obesity and type two diabetes (T2D). Variants in human IMP2/IGF2BP2 gene are associated with increased risk of T2D. However, little is known about its role in adipogenesis and in insulin resistance. Here, we investigate the function of IMP2 during adipocyte development. Mice with Imp2 deletion in mesenchymal stem cells (MSC) are resistant to diet-induced obesity without glucose and insulin tolerance affected. Imp2 is essential for the early commitment of adipocyte-derived stem cells (ADSC) into preadipocytes, but the deletion of Imp2 in MSC is not required for the proliferation and terminal differentiation of committed preadipocytes. Mechanistically, Imp2 binds Wnt receptor Fzd8 mRNA and promotes its degradation by recruiting CCR4-NOT deadenylase complex in an mTOR-dependent manner. Our data demonstrate that Imp2 is required for maintaining white adipose tissue homeostasis through controlling mRNA stability in ADSC. However, the contribution of IMP2 to insulin resistance, a main risk of T2D, is not evident.
- 11 October 2022
- Published by American Diabetes Association in Diabetes
- Vol. 72 (1) , 33-44
Open AccessHuman T2D-Associated Gene IMP2/IGF2BP2 Promotes the Commitment of Mesenchymal Stem Cells Into Adipogenic Lineage
Excessive adiposity is the main cause of obesity and type two diabetes (T2D). Variants in human IMP2/IGF2BP2 gene are associated with increased risk of T2D. However, little is known about its role in adipogenesis and in insulin resistance. Here, we investigate the function of IMP2 during adipocyte development. Mice with Imp2 deletion in mesenchymal stem cells (MSC) are resistant to diet-induced obesity without glucose and insulin tolerance affected. Imp2 is essential for the early commitment of adipocyte-derived stem cells (ADSC) into preadipocytes, but the deletion of Imp2 in MSC is not required for the proliferation and terminal differentiation of committed preadipocytes. Mechanistically, Imp2 binds Wnt receptor Fzd8 mRNA and promotes its degradation by recruiting CCR4-NOT deadenylase complex in an mTOR-dependent manner. Our data demonstrate that Imp2 is required for maintaining white adipose tissue homeostasis through controlling mRNA stability in ADSC. However, the contribution of IMP2 to insulin resistance, a main risk of T2D, is not evident.
- Open Access
- 1 June 2021
- Published by Elsevier in Molecular Metabolism
- Vol. 48, 101209
RNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression
- 1 June 2021
- Published by Elsevier in Molecular Metabolism
- Vol. 48, 101209
Open AccessRNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression
- 1 September 2020
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 31 (9) , 670-679
The Diverse Functions of IMP2/IGF2BP2 in Metabolism
- 1 September 2020
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 31 (9) , 670-679
The Diverse Functions of IMP2/IGF2BP2 in Metabolism